453 related articles for article (PubMed ID: 19437364)
1. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
[TBL] [Abstract][Full Text] [Related]
2. Pathology of radiation and anthracycline cardiotoxicity.
Berry GJ; Jorden M
Pediatr Blood Cancer; 2005 Jun; 44(7):630-7. PubMed ID: 15825155
[TBL] [Abstract][Full Text] [Related]
3. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
4. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
5. Exercise echocardiography reflects cumulative anthracycline exposure during childhood.
Smibert E; Carlin JB; Vidmar S; Wilkinson LC; Newton M; Weintraub RG
Pediatr Blood Cancer; 2004 Jun; 42(7):556-62. PubMed ID: 15127409
[TBL] [Abstract][Full Text] [Related]
6. Assessment of anthracycline-induced cardiotoxicity with electrocardiography.
Horacek JM; Jakl M; Horackova J; Pudil R; Jebavy L; Maly J
Exp Oncol; 2009 Jun; 31(2):115-7. PubMed ID: 19550402
[TBL] [Abstract][Full Text] [Related]
7. Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH.
Marx M; Langer T; Graf N; Hausdorf G; Stöhr W; Ludwig R; Beck JD
Med Pediatr Oncol; 2002 Jul; 39(1):18-24. PubMed ID: 12116074
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention.
Adams MJ; Lipshultz SE
Pediatr Blood Cancer; 2005 Jun; 44(7):600-6. PubMed ID: 15856486
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults.
Larsen RL; Jakacki RI; Vetter VL; Meadows AT; Silber JH; Barber G
Am J Cardiol; 1992 Jul; 70(1):73-7. PubMed ID: 1615874
[TBL] [Abstract][Full Text] [Related]
10. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer.
Guldner L; Haddy N; Pein F; Diallo I; Shamsaldin A; Dahan M; Lebidois J; Merlet P; Villain E; Sidi D; Sakiroglu O; Hartmann O; Leftakopoulos D; de Vathaire F
Radiother Oncol; 2006 Oct; 81(1):47-56. PubMed ID: 16989913
[TBL] [Abstract][Full Text] [Related]
12. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
13. [Severe heart failure in consequence of late anthracycline-induced cardiotoxicity--case report].
Urbanová D; Bubanská E; Hrebík M; Mladosievicová B
Klin Onkol; 2009; 22(1):34-7. PubMed ID: 19534438
[TBL] [Abstract][Full Text] [Related]
14. [Cardiotoxicity of anthracyclines].
Ferrière M; Donadio D; Ramirez R
Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():53-8. PubMed ID: 8215791
[TBL] [Abstract][Full Text] [Related]
15. Clinical spectrum of anthracycline antibiotic cardiotoxicity.
Bristow MR; Billingham ME; Mason JW; Daniels JR
Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861
[TBL] [Abstract][Full Text] [Related]
16. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
Mortensen SA; Aabo K; Jonsson T; Baandrup U
Int J Clin Pharmacol Res; 1986; 6(2):137-50. PubMed ID: 3459718
[TBL] [Abstract][Full Text] [Related]
17. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
[TBL] [Abstract][Full Text] [Related]
18. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
[TBL] [Abstract][Full Text] [Related]
19. [Cardiac toxicity of cancer treatment regimes in children and adolescents: physiopathology, clinical data and the paediatric oncologist's point of view].
Pein F; Iserin L; de Vathaire F; Lemerle J
Bull Cancer; 2004 Nov; 91 Suppl 3():185-91. PubMed ID: 15899626
[TBL] [Abstract][Full Text] [Related]
20. [Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?].
Erlaky H; Tóth K; Szabolcs J; Horváth E; Kemény V; Müller J; Csóka M; Jókúti L; Erdélyi D; Kovács G
Magy Onkol; 2006; 50(1):25-32. PubMed ID: 16617380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
